Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection
Clinical trial NCT04539483 · TERMINATED
Trial details
- NCT number
- NCT04539483
- Sponsor
- Heidelberg ImmunoTherapeutics GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2023-05-31
- Enrollment
- 761
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.